Short Interest in Tiziana Life Sciences Ltd (NASDAQ:TLSA) Decreases By 20.0%

Tiziana Life Sciences Ltd (NASDAQ:TLSA) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 257,800 shares, a decline of 20.0% from the March 31st total of 322,200 shares. Based on an average daily volume of 149,600 shares, the short-interest ratio is presently 1.7 days.

Tiziana Life Sciences Stock Performance

Tiziana Life Sciences stock opened at $0.78 on Friday. The company’s 50-day moving average is $0.52 and its 200-day moving average is $0.57. Tiziana Life Sciences has a fifty-two week low of $0.41 and a fifty-two week high of $1.27.

Tiziana Life Sciences Company Profile

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.